0000899243-22-004869.txt : 20220204 0000899243-22-004869.hdr.sgml : 20220204 20220204175028 ACCESSION NUMBER: 0000899243-22-004869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Day Steven J CENTRAL INDEX KEY: 0001845281 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 22594895 MAIL ADDRESS: STREET 1: 2344 BANYAN DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90049 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-02 0 0001098972 AGENUS INC AGEN 0001845281 O'Day Steven J C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 0 1 0 0 Chief Medical Officer Common Stock 2022-02-02 4 A 0 101682 2.51 A 163003 D Reflects the executive's 2021 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a 6-month lockup restriction with 25% of the award released on the 3-month anniversary of the issuance date and 75% of the award released on the 6-month anniversary. $2.51 was the fair market value of our Common Stock on February 2, 2022, the stock issuance date. /s/ Steven J. O'Day 2022-02-04